State settlement adds $3.5 million to Medicaid by [email protected] | Nov 17, 2010 A state settlement with GlaxoSmithKline drug company will mean $3.5 million for the Medicaid program. The company had been accused nationally of selling adulterated drugs. The settlement is part of a national lawsuit against GlaxoSmithKline. Share this:FacebookTwitterLinkedInWhatsAppEmail